IP Library Granted Patent US 7,119,064
Granted Patent B2
US 7,119,064 · App. 10/691,157 · Granted Oct 10, 2006

Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

Assignee: Board of Regents, The University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,119,064
App. No.
10/691,157
Granted
Oct 10, 2006
Kind
B2
Abstract

The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as modulators of intracellular signaling molecules, for example.

Claims (14)

1. A method of modulating an intracellular signaling molecule in a cell, the method comprising contacting the cell with an effective amount of a modulator selected from the group consisting of colostrinin, a constituent peptide of colostrinin, and combinations thereof, under conditions effective to accomplish at least one of the following:

reduce 4-hydroxynonenal (4HNE)-protein adduct formation;

inhibit 4HNE-mediated glutathione depletion;

inhibit 4HNE-induced activation of p53 protein; or

inhibit 4HNE-induced activation of c-Jun NH2-tenninal kinases;

wherein the constituent peptide of colostrinin is selected from the group consisting of MQPPPLP (SEQ ID NO:1) LQTPQPLLQVMMEPQGD (SEQ ID NO:2), DQPPDVEKPDLQPFQVQS (SEQ ID NO:3), LFFFLPVVNVLP (SEQ ID NO:4), DLEMPVLPVEPFPFV (SEQ ID NO:5), MPQNFYKLPQM (SEQ ID NO:6), VLEMKFPPPPQETVT (SEQ ID NO:7), and LKPFPLKVEVFPFP (SEQ ID NO:8).

2. The method of claim 1 wherein the cell is present in a cell culture, a tissue, an organ, or an organism.

3. The method of claim 1 wherein the cell is a mammalian cell.

4. The method of claim 3 wherein the cell is a human cell.

5. The method of claim 1 wherein the modulator is a constituent peptide of colostrinin.

6. The method of claim 5 wherein the modulator is selected from the group of MQPPPLP (SEQ ID NO:1), LQTPQPLLQVMMEPQGD (SEQ ID NO:2), DQPPDVEKPDLQPFQVQS (SEQ ID NO:3), LFFFLPVVNVLP (SEQ ID NO:4), DLEMPVLPVEPFPFV (SEQ ID NQ:5), MPQNFYKLPQM (SEQ ID NO:6), VLEMKFPPPPQETVT (SEQ ID NQ:7), LKPFPKLKVEVFPFP (SEQ ID NO:8), and combinations thereof.

7. A method of down regulating the 4-hydroxynonenal (4HNE)-mediated oxidative damage associated with lipid peroxidation in a cell, the method comprising contacting the cell with an effective amount of a modulator selected from the group consisting of colostrinin, a constituent peptide of colostrinin, and combinations thereof;

wherein the constituent peptide of colostrinin is selected from the group consisting of SEQ ID NO:1 through SEQ ID NO:8;

and wherein 4HNE-mediated oxidative damage associated with lipid peroxidation in the cell is down regulated.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2004
From: BOLDOGH, ISTVAN; STANTON, G. JOHN; GEORGIADES, JERZY A.; HUGHES, THOMAS K., JR.; KRUZEL, MARIAN
To: TEXAS SYSTEM, THE UNIVERSITY OF, BOARD OF REGENTS
Reel/Frame 014733/0960 →
Continuity (5)
Continuation In Part 1028165200 · Oct 28, 2002
Division 0964180300 · Aug 17, 2000
Provisional Application 6042036900 · Oct 22, 2002
Provisional Application 6014931000 · Aug 17, 1999
Related Publication 20040266681A1 · Dec 30, 2004